Injected hyaluronidase reduces Restylane-mediated cutaneous augmentation

Archives of Facial Plastic Surgery

Volumn 7, Issue 4, 2005, Pages 231-237

  Vartanian, A John ^a,b,d   Frankel, Andrew S ^b,c   Rubin, Mark G ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Lasky Clinic   (United States)

^d Lasky Skin Clinic ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; DRUG DERIVATIVE; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; RESTYLANE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; MALE; MATERIALS TESTING; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADULT; BIOCOMPATIBLE MATERIALS; FEMALE; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; INJECTIONS, INTRADERMAL; MALE; MATERIALS TESTING; MIDDLE AGED; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD;

EID: 27244457132     PISSN: 15212491     EISSN: 15383660     Source Type: Journal    
DOI: 10.1001/archfaci.7.4.231     Document Type: Article

References (22)

1. Friedman PM, Mafong EA, Kauvar ANB, Geronemus RG. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg. 2002;28:491-494.
2. Narins RS, Brandt R, Leyden J, Lorenc ZP, Rubbin MG, Smith S. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003; 29:588-595.
3. Carruthers J, Carruthers A. A prospective, randomized, parallel group study analyzing the effect of BTX-A (Botox) and nonanimal sourced hyaluronic acid (NASHA, Restylane) in combination compared with NASHA (Restylane) alone in severe glabellar rhytides in adult female subjects: treatment of severe glabellar rhytides with a hyaluronic acid derivative compared with the derivative and BTX-A. Dermatol Surg. 2003;29:802-809.
4. Andre P. Evaluation of the safety of a non-animal stabilized hyaluronic acid (NASHA-Q-Medical, Sweden) in European countries: a retrospective study from 1997 to 2001. J Eur Acad Dermatol Venereol. 2004;18:422-425.
5. Merck & Co Inc. The Merck Index. 13th ed. White Station, NJ: Merck & Co Inc; 2001:4777.
6. Clark LE, Mellette JR Jr. The use of hyaluronidase as an adjunct to surgical procedures. J Dermatol Surg Oncol. 1994;20:842-844.
7. Nevarre DR, Tzarnas CD. The effects of hyaluronidase on the efficacy and on the pain administration of 1% lidocaine. Plast Reconstr Surg. 1998;101:365-369.
8. Merchant B; Merchant-Taylor International Inc [letter]. Available at: http://www .fda.gov/ohrms/dockets/dailys/03/jul03/072503/02p-0506-c000001-vol1. pdf. Accessed May 11, 2005.
9. Department of Health and Human Services. Federal Register Notice. Available at: http://www.fda.gov/ohrms/dockets/98fr/03-27880.pdf. Accessed May 11, 2005.
10. US Food and Drug Administration. A catalog of FDA approved drug products. Available at: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm ?fuseaction=Search.Overview&DrugName=AMPHADASE. Accessed May 11, 2005.
11. US Food and Drug Administration. A catalog of FDA approved drug products. Available at: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm ?fuseaction=Search.Overview&DrugName=VITRASE. Accessed May 11, 2005.
12. Kirby B, Butt A, Morrison AM, Beck MH. Type I allergic reaction to hyaluronidase during ophthalmic surgery. Contact Dermatitis. 2001;44:52.
13. Eberhart AH, Weiler CR, Erie JC. Angioedema related to the use of hyaluronidase in cataract surgery. Am J Ophthalmol. 2004;138:142-143.
14. Minning CA Jr. Hyaluronidase allergy simulating expulsive choroidal hemorrhage. Arch Ophthalmol. 1994;112:585-586.
15. Taylor IS, Pollowitz JA. A little-known phenomenon: allergic reaction to hyaluronidase. Ophthalmology. 1984;91:1003.
16. Kind LS, Roffler S. Allergic reactions to hyaluronidase. Proc Soc Exp Biol Med. 1961;106:734-735.
17. Kempeneers R, Draland L, Ceuppens J. Hyaluronidase induced orbital pseudomotor as a complication of retrobulbar anaesthesia. Bull Belgian Soc Ophthalmol. 1992;243:159-166.
18. Ahluwalia HS, Lukaris A, Lane CM. Delayed allergic reaction to hyaluronidase: a rare sequel to cataract surgery. Eye. 2003;17:263-266.
19. Quhill F, Bowling B, Packard RB. Hyaluronidase allergy after peribulbar anesthesia with orbital inflammation. J Cataract Refract Surg. 2004;30:916-917.
20. Szepfalusi Z, Nentwich I, Dobner M, Pilwein K, Urbanek R. IgE-mediated allergic reaction to hyaluronidase in paediatric oncological patients. Eur J Pediatr. 1997; 156:199-203.
21. King TP, Spangfort MD. Structure and biology of stinging insect venom allergens. Int Arch Allergy Immunol. 2000;123:99-106.
22. Franklin R, Baer H. Comparison of honeybee venoms and their components from various sources. J Allergy Clin Immunol. 1975;55:285-298.